These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7312841)

  • 41. Phase I clinical trial in healthy adults of a nasal vaccine candidate containing recombinant hepatitis B surface and core antigens.
    Betancourt AA; Delgado CA; Estévez ZC; Martínez JC; Ríos GV; Aureoles-Roselló SR; Zaldívar RA; Guzmán MA; Baile NF; Reyes PA; Ruano LO; Fernández AC; Lobaina-Matos Y; Fernández AD; Madrazo AI; Martínez MI; Baños ML; Alvarez NP; Baldo MD; Mestre RE; Pérez MV; Martínez ME; Escobar DA; Guanche MJ; Cáceres LM; Betancourt RS; Rando EH; Nieto GE; González VL; Rubido JC
    Int J Infect Dis; 2007 Sep; 11(5):394-401. PubMed ID: 17257877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.
    Knöll A; Boehm S; Hahn J; Holler E; Jilg W
    J Viral Hepat; 2007 Jul; 14(7):478-83. PubMed ID: 17576389
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical, serological and molecular characteristics of 471 hepatitis B virus carriers.
    Bar-Shany S; Shohat T; Tur-Kaspa R; Slepon R; Heering S; Lerman Y; Green M; Gilon E
    Isr J Med Sci; 1994 Apr; 30(4):263-6. PubMed ID: 8175326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence of hepatitis B and C and blood donors.
    Mehdi SR; Pophali A; Al-Abdul Rahim KA
    Saudi Med J; 2000 Oct; 21(10):942-4. PubMed ID: 11369958
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High prevalence of hepatitis B, C and delta virus infections among blood donors in Mongolia.
    Tsatsralt-Od B; Takahashi M; Nishizawa T; Inoue J; Ulaankhuu D; Okamoto H
    Arch Virol; 2005 Dec; 150(12):2513-28. PubMed ID: 16012782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The impact of hepatitis B vaccination in Italy and the advent of novel recombinant vaccines containing pre-S1 and pre-S2].
    Romanò L; Biffi R; Bianchi S; Zanetti A
    Ann Ig; 2002; 14(3 Suppl 3):19-25. PubMed ID: 12389407
    [No Abstract]   [Full Text] [Related]  

  • 47. Vaccination with recombinant HBsAg-HBIG complex in healthy adults.
    Xu DZ; Huang KL; Zhao K; Xu LF; Shi N; Yuan ZH; Wen YM
    Vaccine; 2005 Apr; 23(20):2658-64. PubMed ID: 15780449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination.
    Bauer T; Jilg W
    Vaccine; 2006 Jan; 24(5):572-7. PubMed ID: 16171909
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Vaccine against hepatitis B].
    Garassini M
    G E N; 1982; 36(2-3):193-8. PubMed ID: 6821346
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinical and prognostic values of anti-hepatitis B core immunoglobulin M detection in asymptomatic hepatitis B surface antigen carriers.
    Ali HY; Faransawy ZE; Al-Megthab NA
    Saudi Med J; 2002 Jul; 23(7):777-81. PubMed ID: 12174223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Frequent detection of hepatitis B core antibodies in heart transplant recipients without preceding hepatitis B infection.
    Tenderich G; Zittermann A; Prohaska W; Wlost S; Fuchs U; Gürsoy D; Minami K; Koerfer R
    Transplant Proc; 2005 Dec; 37(10):4522-4. PubMed ID: 16387159
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Prevalence of serum markers of hepatitis B and C virus in blood donors of Nouakchott, Mauritania].
    Lo BB; Meymouna M; Boulahi MA; Tew M; Sow A; Ba A; Sow MB
    Bull Soc Pathol Exot; 1999 May; 92(2):83-4. PubMed ID: 10399594
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prevalence of viral markers for hepatitis B, C and human immunodeficiency virus in volunteer blood donors in Northeast Mexico].
    Ayala Gaytán JJ; Guerra Avalos FJ; Mora Brondo P; Casillas Romo A
    Rev Gastroenterol Mex; 1997; 62(4):250-3. PubMed ID: 9528294
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation and determination of immunological activities of anti-HBV egg yolk extraction.
    Xu YP; Zou WM; Zhan XJ; Yang SH; Xie DZ; Peng SL
    Cell Mol Immunol; 2006 Feb; 3(1):67-71. PubMed ID: 16549053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran.
    Ghavanini AA; Sabri MR
    East Mediterr Health J; 2000; 6(5-6):1114-6. PubMed ID: 12197336
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Seroprevalence of hepatitis B and C virus infections among Lao blood donors.
    Jutavijittum P; Yousukh A; Samountry B; Samountry K; Ounavong A; Thammavong T; Keokhamphue J; Toriyama K
    Southeast Asian J Trop Med Public Health; 2007 Jul; 38(4):674-9. PubMed ID: 17883005
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
    Manzini P; Girotto M; Borsotti R; Giachino O; Guaschino R; Lanteri M; Testa D; Ghiazza P; Vacchini M; Danielle F; Pizzi A; Valpreda C; Castagno F; Curti F; Magistroni P; Abate ML; Smedile A; Rizzetto M
    Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Allergic diseases in patients with viral hepatitis B].
    Gavura VV
    Vrach Delo; 1988 Nov; (11):97-9. PubMed ID: 3238994
    [No Abstract]   [Full Text] [Related]  

  • 59. Hepatitis B immunoglobulin.
    Cossart Y; Gust I; Schiff P
    Med J Aust; 1982 May; 1(10):407-8. PubMed ID: 7099066
    [No Abstract]   [Full Text] [Related]  

  • 60. [Selection of suitable individuals for the preparation of specific immunoglobulin against hepatitis B (author's transl)].
    Novák J; Kselíková M
    Cas Lek Cesk; 1978 Feb; 117(6):186-7. PubMed ID: 647727
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.